Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Retatrutide for type 2 diabetes: Phase 2 trial results (36-week study, HbA1c reductions, weight loss) New England Journal of Medicine (2023) Jastreboff AM, et al
It optimizes dosage delivery precision, enhancing medication efficacy and patient outcomes
The physical reconstitution process matters just as much
Store under refrigeration 2 to 8C (36 to 46F)
Research Use Only Notice This product is intended for laboratory research use only and is not approved for human or veterinary use
CMS periodically rationalises brand-specific J-codes when a drug becomes widely available across multiple manufacturers
US$ 29.55
US$ 25.20
US$ 29.44
US$ 26.61
US$ 26.27
